Inferring ligand-receptor cellular networks from bulk and spatial transcriptomic datasets with BulkSignalR.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
05 May 2023
Historique:
accepted: 22 04 2023
revised: 24 03 2023
received: 17 11 2022
medline: 5 5 2023
pubmed: 5 5 2023
entrez: 5 5 2023
Statut: aheadofprint

Résumé

The study of cellular networks mediated by ligand-receptor interactions has attracted much attention recently owing to single-cell omics. However, rich collections of bulk data accompanied with clinical information exists and continue to be generated with no equivalent in single-cell so far. In parallel, spatial transcriptomic (ST) analyses represent a revolutionary tool in biology. A large number of ST projects rely on multicellular resolution, for instance the Visium™ platform, where several cells are analyzed at each location, thus producing localized bulk data. Here, we describe BulkSignalR, a R package to infer ligand-receptor networks from bulk data. BulkSignalR integrates ligand-receptor interactions with downstream pathways to estimate statistical significance. A range of visualization methods complement the statistics, including functions dedicated to spatial data. We demonstrate BulkSignalR relevance using different datasets, including new Visium liver metastasis ST data, with experimental validation of protein colocalization. A comparison with other ST packages shows the significantly higher quality of BulkSignalR inferences. BulkSignalR can be applied to any species thanks to its built-in generic ortholog mapping functionality.

Identifiants

pubmed: 37144485
pii: 7152875
doi: 10.1093/nar/gkad352
pmc: PMC10250239
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : J.C.
ID : INCa R17080FF-CT
Organisme : Fondation ARC pour la Recherche sur le Cancer
ID : PJA 20141201975
Organisme : Région Occitanie, programme Recherche et Société(s)
Organisme : European Union

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of Nucleic Acids Research.

Références

Nature. 2018 Nov;563(7731):347-353
pubmed: 30429548
Dev Cell. 2017 Jan 23;40(2):193-201
pubmed: 28089369
Bioinformatics. 2012 Mar 1;28(5):694-700
pubmed: 22210865
Annu Rev Pathol. 2011;6:49-69
pubmed: 20887192
Nature. 2017 May 18;545(7654):360-364
pubmed: 28489825
Nat Genet. 2021 Sep;53(9):1334-1347
pubmed: 34493872
Theranostics. 2020 Mar 15;10(10):4383-4394
pubmed: 32292502
Cell. 2017 Jul 27;170(3):564-576.e16
pubmed: 28753430
Nat Methods. 2021 Jan;18(1):9-14
pubmed: 33408395
Nat Commun. 2022 Jun 9;13(1):3224
pubmed: 35680885
Nat Methods. 2007 Mar;4(3):207-14
pubmed: 17327847
Nat Commun. 2015 Jul 22;6:7866
pubmed: 26198319
Cancer Med. 2016 Dec;5(12):3572-3578
pubmed: 27770511
J Stat Softw. 2010;33(1):1-22
pubmed: 20808728
Mol Cancer. 2018 Feb 19;17(1):45
pubmed: 29455668
J Oncol. 2019 Jul 11;2019:8707053
pubmed: 31379945
Exp Cell Res. 2003 Mar 10;284(1):2-13
pubmed: 12648462
Cancer Res Treat. 2012 Sep;44(3):151-6
pubmed: 23091440
Sci Transl Med. 2015 Aug 26;7(302):302ra136
pubmed: 26311731
Nat Commun. 2021 Feb 17;12(1):1089
pubmed: 33597528
Nat Methods. 2020 Feb;17(2):159-162
pubmed: 31819264
Cell. 2010 Apr 2;141(1):52-67
pubmed: 20371345
Cell Rep. 2015 Feb 24;10(7):1187-201
pubmed: 25704820
J Cell Biol. 2013 Apr 15;201(2):279-92
pubmed: 23589494
Trends Cell Biol. 2014 Jan;24(1):26-34
pubmed: 24295852
Oncogene. 2013 Mar 14;32(11):1341-50
pubmed: 22580613
Bioinformatics. 2022 Sep 16;38(Suppl_2):ii141-ii147
pubmed: 36124800
Nucleic Acids Res. 2022 Jan 7;50(D1):D687-D692
pubmed: 34788843
Hum Mol Genet. 2011 Mar 1;20(5):905-16
pubmed: 21147753
Elife. 2017 Dec 21;6:
pubmed: 29268862
Oncogene. 2022 Mar;41(10):1410-1420
pubmed: 35031773
Nat Genet. 2000 May;25(1):25-9
pubmed: 10802651
Nat Med. 2010 Jul;16(7):781-7
pubmed: 20581836
Nat Commun. 2022 Jul 30;13(1):4429
pubmed: 35908020
Nat Commun. 2020 May 8;11(1):2285
pubmed: 32385277
Sci Transl Med. 2011 Mar 2;3(72):72ra17
pubmed: 21368222
J Cell Biol. 2009 May 18;185(4):743-54
pubmed: 19433454
Nat Med. 2021 May;27(5):820-832
pubmed: 33958794
J Pathol. 1995 Dec;177(4):363-8
pubmed: 8568590
Cell Rep. 2018 Jan 16;22(3):600-610
pubmed: 29346760
Cell. 2017 Oct 19;171(3):683-695.e18
pubmed: 28988771
Cell Commun Adhes. 2003 Mar-Apr;10(2):105-18
pubmed: 14681060
Clin Cancer Res. 2016 Sep 15;22(18):4623-33
pubmed: 27103403
Nat Neurosci. 2021 Mar;24(3):425-436
pubmed: 33558695
Clin Cancer Res. 2013 Jan 1;19(1):279-90
pubmed: 23091115
Cell. 2017 Dec 14;171(7):1611-1624.e24
pubmed: 29198524
Oncotarget. 2020 Sep 29;11(39):3590-3600
pubmed: 33062195
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
pubmed: 10592173
J Biol Chem. 2005 Sep 16;280(37):32468-79
pubmed: 15994311
Br J Cancer. 1992 Apr;65(4):573-7
pubmed: 1314069
Neoplasia. 2015 May;17(5):421-33
pubmed: 26025665
Nat Protoc. 2020 Apr;15(4):1484-1506
pubmed: 32103204
Microbiol Mol Biol Rev. 2004 Jun;68(2):320-44
pubmed: 15187187
Nature. 2019 Jul;571(7766):505-509
pubmed: 31243369
Nucleic Acids Res. 2020 Jan 8;48(D1):D489-D497
pubmed: 31647099
Lancet Oncol. 2017 Jan;18(1):42-51
pubmed: 27932068
Nucleic Acids Res. 2020 Jun 4;48(10):e55
pubmed: 32196115
Nat Commun. 2021 Oct 14;12(1):6012
pubmed: 34650042
Cell Rep. 2018 Nov 6;25(6):1458-1468.e4
pubmed: 30404002

Auteurs

Jean-Philippe Villemin (JP)

Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm U 1194, Montpellier, France.
Université de Montpellier, Montpellier, France.
Institut régional du Cancer Montpellier (ICM), Montpellier, France.

Laia Bassaganyas (L)

Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm U 1194, Montpellier, France.
Université de Montpellier, Montpellier, France.
Institut régional du Cancer Montpellier (ICM), Montpellier, France.

Didier Pourquier (D)

Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm U 1194, Montpellier, France.
Institut régional du Cancer Montpellier (ICM), Montpellier, France.

Florence Boissière (F)

Institut régional du Cancer Montpellier (ICM), Montpellier, France.

Simon Cabello-Aguilar (S)

Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm U 1194, Montpellier, France.
Université de Montpellier, Montpellier, France.
Institut régional du Cancer Montpellier (ICM), Montpellier, France.

Evelyne Crapez (E)

Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm U 1194, Montpellier, France.
Institut régional du Cancer Montpellier (ICM), Montpellier, France.

Rita Tanos (R)

Institut régional du Cancer Montpellier (ICM), Montpellier, France.

Emmanuel Cornillot (E)

Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm U 1194, Montpellier, France.
Université de Montpellier, Montpellier, France.
Institut régional du Cancer Montpellier (ICM), Montpellier, France.
Faculté de Pharmacie, Université de Montpellier, Montpellier, France.

Andrei Turtoi (A)

Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm U 1194, Montpellier, France.
Université de Montpellier, Montpellier, France.
Institut régional du Cancer Montpellier (ICM), Montpellier, France.

Jacques Colinge (J)

Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm U 1194, Montpellier, France.
Université de Montpellier, Montpellier, France.
Institut régional du Cancer Montpellier (ICM), Montpellier, France.
Faculté de Médecine, Université de Montpellier, Montpellier, France.

Classifications MeSH